PRMT5 and colorectal carcinoma: Although PRMT5 has been reported to methylate H3R8, H3R2, and H4R3 to facilitate transcriptional activation or regression in cancer[97], there are few studies related to the exact site methylated by PRMT5 in the process of CRC metastasis.